SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 8a2d.1

EGFR kinase domain (L858R/V948R) in complex with 2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-7-methyl-indazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-thiazol-2-yl-acetamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.11 Å
Oligo State
monomer
Ligands
1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
1 x KXY: (2R)-2-[4-[bis(fluoranyl)methyl]-6-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-7-methyl-indazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-(1,3-thiazol-2-yl)ethanamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Obst-Sander, U. et al., Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib. J.Med.Chem. (2022)
Release Date
2022-10-19
Peptides
Epidermal growth factor receptor: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence

8a2b.1